文献速递泌尿生殖MR

在3T多参数前列腺MRI上停止主动监测的前列腺癌患者的影像学特征

Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
PubMed 文献 · AJR Am J Roentgenol · 2017-01-11

本研究基于Winthrop大学医院泌尿外科前瞻性数据库,纳入114例主动监测前列腺癌患者,其中14例因随访多参数MRI提示肿瘤进展而停止监测。随访MRI显示病灶增大或更突出3例(21.4%)、新发可疑病灶2例(14.3%)、可疑或确认包膜外侵犯9例(64.3%);7例(50.0%)行活检,6例(42.9%)证实肿瘤升级。作者认为多参数MRI有助于监测主动监测患者并可能识别适合根治性治疗的临床显著癌。

要点

  • 随访多参数MRI提示进展而停止主动监测者中,包膜外侵犯征象最常见(9/14,64.3%)。
  • 停止监测后活检证实肿瘤升级者占6/14(42.9%)。
  • 病灶增大或更突出占3/14(21.4%),新发可疑病灶占2/14(14.3%)。

核心结论

  • 随访多参数MRI显示疾病加重的患者数量虽少,但支持MRI在早期前列腺癌患者中的作用;多参数MRI有助于监测主动监测患者,并可能识别适合根治性治疗的临床显著癌。

研究设计与样本

  • 基于Winthrop大学医院泌尿外科前瞻性维护的主动监测前列腺癌患者数据库;当时共200例患者接受主动监测,其中114例有主动监测开始前的初始多参数MRI及至少一次主动监测开始后的随访多参数MRI;MRI表现与可获得病理结果进行对照。

关键影像表现/征象

  • 随访MRI显示病灶较前次MRI增大或更突出者3例(21.4%)。
  • 随访MRI显示新发一个或多个可疑癌病灶者2例(14.3%)。
  • 随访MRI显示可疑或确认包膜外侵犯者9例(64.3%)。

诊断标准与关键数值

  • 14例因随访MRI改变提示癌症进展而停止主动监测。
  • 14例中7例(50.0%)在随访多参数MRI后行活检,其中6例(42.9%)活检结果导致肿瘤升级。
  • 主动监测持续时间为4至110个月。

临床应用与阅片要点

  • 本研究中心的做法是主动监测方案采用每年MRI替代系列活检,仅在临床必要时进行活检。
  • 随访多参数MRI上病灶增大或更突出、新发可疑病灶、可疑或确认包膜外侵犯是提示进展并导致停止主动监测的影像改变。
  • 所有停止主动监测的患者均接受了根治性治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Early-stage prostate cancer may be followed with active surveillance to avoid overtreatment. Our institution's active surveillance regimen uses annual MRI in place of serial biopsies, and biopsies are performed only when clinically necessary. The objective of our study was to report the multiparametric MRI characteristics of prostate cancer patients who discontinued active surveillance at our institution after repeat imaging revealed possible evidence of tumor upgrading.

MATERIALS AND METHODS: The Department of Urology at Winthrop University Hospital prospectively maintains a database of prostate cancer patients who are monitored with active surveillance. At the time of this study, there were 200 prostate cancer patients being monitored with active surveillance. Of those patients, 114 patients had an initial multiparametric MRI study that was performed before active surveillance started and at least one follow-up multiparametric MRI study that was performed after active surveillance began. The MRI findings were evaluated and correlated with pathology results, if available.

RESULTS: Fourteen patients discontinued active surveillance because changes on follow-up MRI suggested progression of cancer. Follow-up MRI showed an enlarged or more prominent lesion compared with the appearance on a previous MRI in three (21.4%) patients, a new lesion or lesions suspicious for cancer in two (14.3%) patients, and findings suspicious for or confirming extracapsular extension in nine (64.3%) patients. Seven of the 14 (50.0%) patients had a biopsy after follow-up multiparametric MRI, and biopsy results led to tumor upgrading in six of the 14 (42.9%) patients. The duration of active surveillance ranged from 4 to 110 months. All patients received definitive treatment.

CONCLUSION: The small number of patients with follow-up multiparametric MRI findings showing worsening disease supports the role of MRI in patients with early-stage prostate cancer. Multiparametric MRI is useful in monitoring patients on active surveillance and may identify patients with clinically significant cancer amenable to definitive treatment.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Habibian DJ, Liu CC, Dao A, et al. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI. AJR Am J Roentgenol. 2017. PMID: 28075651. doi:10.2214/AJR.16.16822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。